Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 1
2014 1
2017 2
2018 3
2019 3
2020 5
2021 7
2022 6
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
CD19-Targeted Immunotherapy Attenuates Vessel Wall Inflammation.
Derlin T, Koenecke C, Schultze-Florey C, Ganser A, Bengel FM. Derlin T, et al. Among authors: schultze florey c. JACC Cardiovasc Imaging. 2021 Sep;14(9):1864-1866. doi: 10.1016/j.jcmg.2021.02.025. Epub 2021 Apr 14. JACC Cardiovasc Imaging. 2021. PMID: 33865774 Free article. No abstract available.
BNT162b2-boosted immune responses six months after heterologous or homologous ChAdOx1nCoV-19/BNT162b2 vaccination against COVID-19.
Behrens GMN, Barros-Martins J, Cossmann A, Ramos GM, Stankov MV, Odak I, Dopfer-Jablonka A, Hetzel L, Köhler M, Patzer G, Binz C, Ritter C, Friedrichsen M, Schultze-Florey C, Ravens I, Willenzon S, Bubke A, Ristenpart J, Janssen A, Ssebyatika G, Krähling V, Bernhardt G, Hoffmann M, Pöhlmann S, Krey T, Bošnjak B, Hammerschmidt SI, Förster R. Behrens GMN, et al. Among authors: schultze florey c. Nat Commun. 2022 Aug 18;13(1):4872. doi: 10.1038/s41467-022-32527-2. Nat Commun. 2022. PMID: 35982040 Free PMC article.
Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination.
Barros-Martins J, Hammerschmidt SI, Cossmann A, Odak I, Stankov MV, Morillas Ramos G, Dopfer-Jablonka A, Heidemann A, Ritter C, Friedrichsen M, Schultze-Florey C, Ravens I, Willenzon S, Bubke A, Ristenpart J, Janssen A, Ssebyatika G, Bernhardt G, Münch J, Hoffmann M, Pöhlmann S, Krey T, Bošnjak B, Förster R, Behrens GMN. Barros-Martins J, et al. Among authors: schultze florey c. Nat Med. 2021 Sep;27(9):1525-1529. doi: 10.1038/s41591-021-01449-9. Epub 2021 Jul 14. Nat Med. 2021. PMID: 34262158 Free PMC article.
Neurological management and work-up of neurotoxicity associated with CAR T cell therapy.
Möhn N, Bonda V, Grote-Levi L, Panagiota V, Fröhlich T, Schultze-Florey C, Wattjes MP, Beutel G, Eder M, David S, Körner S, Höglinger G, Stangel M, Ganser A, Koenecke C, Skripuletz T. Möhn N, et al. Among authors: schultze florey c. Neurol Res Pract. 2022 Jan 10;4(1):1. doi: 10.1186/s42466-021-00166-5. Neurol Res Pract. 2022. PMID: 35000613 Free PMC article.
Navigating preemptive and therapeutic donor lymphocyte infusions in advanced myeloid malignancies by high-sensitivity chimerism analysis.
Stadler M, Venturini L, Bünting I, Dammann E, Weissinger EM, Schwarzer A, Schultze-Florey C, Ehrlich S, Markel D, Lueck C, Gladysz A, Fröhlich T, Damrah N, Beutel G, Eder M, Ganser A, Hambach L. Stadler M, et al. Among authors: schultze florey c. Front Oncol. 2022 Aug 17;12:867356. doi: 10.3389/fonc.2022.867356. eCollection 2022. Front Oncol. 2022. PMID: 36059667 Free PMC article.
Healthy-like CD4+ Regulatory and CD4+ Conventional T-Cell Receptor Repertoires Predict Protection from GVHD Following Donor Lymphocyte Infusion.
Schneider J, Kuhlmann L, Xiao Y, Raha S, Bernhardt G, Stadler M, Thol F, Heuser M, Eder M, Ganser A, Ravens S, Förster R, Prinz I, Koenecke C, Schultze-Florey CR. Schneider J, et al. Among authors: schultze florey cr. Int J Mol Sci. 2022 Sep 18;23(18):10914. doi: 10.3390/ijms231810914. Int J Mol Sci. 2022. PMID: 36142824 Free PMC article.
Clonal expansion of CD8+ T cells reflects graft-versus-leukemia activity and precedes durable remission following DLI.
Schultze-Florey CR, Kuhlmann L, Raha S, Barros-Martins J, Odak I, Tan L, Xiao Y, Ravens S, Hambach L, Venturini L, Stadler M, Eder M, Thol F, Heuser M, Förster R, Ganser A, Prinz I, Koenecke C. Schultze-Florey CR, et al. Blood Adv. 2021 Nov 9;5(21):4485-4499. doi: 10.1182/bloodadvances.2020004073. Blood Adv. 2021. PMID: 34535011 Free PMC article.
Spectral flow cytometry cluster analysis of therapeutic donor lymphocyte infusions identifies T cell subsets associated with outcome in patients with AML relapse.
Odak I, Sikora R, Riemann L, Bayir LM, Beck M, Drenker M, Xiao Y, Schneider J, Dammann E, Stadler M, Eder M, Ganser A, Förster R, Koenecke C, Schultze-Florey CR. Odak I, et al. Among authors: schultze florey cr. Front Immunol. 2022 Oct 5;13:999163. doi: 10.3389/fimmu.2022.999163. eCollection 2022. Front Immunol. 2022. PMID: 36275657 Free PMC article.
28 results